Immediate Impact

2 by Nobel laureates 3 from Science/Nature 63 standout
Sub-graph 1 of 24

Citing Papers

Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
1 intermediate paper

Works of Prashanth Prithviraj being referenced

Eftilagimod alpha, a soluble lymphocyte activation gene-3 (LAG-3) protein plus pembrolizumab in patients with metastatic melanoma
2020
Monitoring Immune Checkpoint Regulators as Predictive Biomarkers in Hepatocellular Carcinoma
2018

Author Peers

Author Last Decade Papers Cites
Prashanth Prithviraj 396 308 183 190 28 730
D. Fan 358 401 168 97 23 796
Chang-Long Chen 353 203 102 220 17 597
Tianqiang Jin 278 227 132 233 19 626
Kang Wang 297 358 173 123 28 699
Cecilia Monge 376 338 108 120 29 699
Ashwin Somasundaram 378 289 139 279 29 749
Hilda Wexler 355 195 135 196 27 796
Michitaka Nakano 500 190 86 204 31 718
Qiuzhong Pan 273 373 137 208 41 662
Hongbing Shi 311 154 160 199 24 603

All Works

Loading papers...

Rankless by CCL
2026